Dr. Harry Thomas Temple, MD

Dr. Temple practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Temple's NPI, 1992769517, was assigned on April 12, 2006. Dr. Temple graduated from Sidney Kimmel Medical College in 1986. Dr. Temple holds Florida license ME78837.

Dr. Temple's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Temple's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Temple to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Temple practices, 2 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Temple's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Temple is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Temple's licenses on file in 3 states: Florida, Virginia and Pennsylvania.

Dmand AI lists arm, wrist, hand fracture and dislocation, bursitis, hip replacement, knee replacement, lower back pain, orthopedic surgery of arms and legs, pelvic and hip fracture and removal of damaged skin or skin graft among the conditions Dr. Temple treats.

CMS data shows 218 Medicare services from Dr. Temple across 3 procedure codes in 2024, for 105 Medicare patients. Medicare paid $11,110 for them.

CMS counts 105 Medicare patients who saw Dr. Temple in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Temple's median patient age at 66, with 50% women.

In 2024, Dr. Temple wrote 19 Medicare Part D claims. 79% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Temple for performance year 2024, reported as part of a group. Dr. Temple accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Temple as offering telehealth.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 155 papers to Dr. Temple, published from 2003 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Bone Neoplasms, Magnetic Resonance Imaging and Diagnosis, Differential. Dr. Temple has published most often in Clin Orthop Relat Res. Dr. Temple's most frequent co-authors are Mark S. Mizel, MD, Francis John Hornicek, MD, PhD and John D. Pitcher, MD.

CMS Open Payments shows 43 general payments to Dr. Temple from 5 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 82% of the total. Stryker Corporation paid the most, $36,711.

Dmand AI lists 1 award for Dr. Temple, most recently CMS Stage 1 EHR in 2013.

Dr. Temple graduated from Sidney Kimmel Medical College in 1986. Dr. Temple is a member of AOA.

Dr. Temple is in network with 11 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.